Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study Article Swipe
Francesco Muratore
,
Chiara Marvisi
,
Giulia Cassone
,
Caterina Ricordi
,
Luigi Boiardi
,
Pamela Mancuso
,
Giulia Besutti
,
Lucia Spaggiari
,
Massimiliano Casali
,
Stefania Croci
,
Rexhep Durmo
,
Annibale Versari
,
Gabriella Di Tommaso
,
Mariagrazia Catanoso
,
Paolo Giorgi Rossi
,
Carlo Salvarani
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1093/rheumatology/keae400
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1093/rheumatology/keae400
Objectives To assess the maintenance of efficacy of one year of tocilizumab (TCZ) monotherapy after its discontinuation in large vessel-GCA (LV-GCA). Methods 17 patients with active LV-GCA were previously treated with 3 boluses of intravenous methylprednisone and weekly subcutaneous TCZ in monotherapy for 52 weeks. Patients in relapse-free clinical remission at week 52 discontinued TCZ and entered part two, which was a 26-week observational follow-up period. PET/CT was performed in all patients at the end of the 26-week observational period (week 78). End points were the variation in PET vascular activity score (PETVAS) at week 78 compared with baseline and with week 52, and the proportion of patients with relapse-free clinical remission at week 78 and at the end of the follow-up. Results Compared with baseline, a significant reduction in PETVAS was observed at week 78, mean (95% CI) change −6.6 (−9.5 to −3.7). However, compared with week 52, PETVAS significantly increase 6 months after TCZ discontinuation (week 78), mean (95% CI) change 4.6 (0.7–8.5). The proportion of patients with relapse-free clinical remission at weeks 78 and at the end of the follow-up (median time from TCZ discontinuation 148 weeks) was 11/17 (65%, 95% CI 38–86) and 8/17 (47%, 95% CI 23–72), respectively. Age and sex-adjusted HR (95% CI) for each unit increase of PETVAS indicating subsequent relapse was 1.36 (0.92–2.00). Conclusions One year of TCZ monotherapy was effective in maintaining drug-free clinical remission in LV-GCA. Changes in PETVAS early after TCZ discontinuation may predict subsequent relapses. Trial registration ClinicalTrials.gov, http://clinicaltrials.gov, NCT05394909.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/rheumatology/keae400
- OA Status
- green
- Cited By
- 5
- References
- 13
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4401636276
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4401636276Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/rheumatology/keae400Digital Object Identifier
- Title
-
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-08-16Full publication date if available
- Authors
-
Francesco Muratore, Chiara Marvisi, Giulia Cassone, Caterina Ricordi, Luigi Boiardi, Pamela Mancuso, Giulia Besutti, Lucia Spaggiari, Massimiliano Casali, Stefania Croci, Rexhep Durmo, Annibale Versari, Gabriella Di Tommaso, Mariagrazia Catanoso, Paolo Giorgi Rossi, Carlo SalvaraniList of authors in order
- Landing page
-
https://doi.org/10.1093/rheumatology/keae400Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://hdl.handle.net/11380/1354146Direct OA link when available
- Concepts
-
Medicine, Tocilizumab, Giant cell arteritis, Extension (predicate logic), Prednisolone, Dermatology, Internal medicine, Vasculitis, Rheumatoid arthritis, Disease, Computer science, Programming languageTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
5Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5Per-year citation counts (last 5 years)
- References (count)
-
13Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4401636276 |
|---|---|
| doi | https://doi.org/10.1093/rheumatology/keae400 |
| ids.doi | https://doi.org/10.1093/rheumatology/keae400 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39150490 |
| ids.openalex | https://openalex.org/W4401636276 |
| fwci | 4.31311571 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D013700 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Giant Cell Arteritis |
| mesh[2].qualifier_ui | Q000000981 |
| mesh[2].descriptor_ui | D013700 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | diagnostic imaging |
| mesh[2].descriptor_name | Giant Cell Arteritis |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D061067 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[4].qualifier_ui | Q000008 |
| mesh[4].descriptor_ui | D061067 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | administration & dosage |
| mesh[4].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D005260 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Female |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008297 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Male |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000368 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Aged |
| mesh[8].qualifier_ui | Q000008 |
| mesh[8].descriptor_ui | D005938 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | administration & dosage |
| mesh[8].descriptor_name | Glucocorticoids |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D005938 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Glucocorticoids |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D016896 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Treatment Outcome |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D000072078 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Positron Emission Tomography Computed Tomography |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D008875 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Middle Aged |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D004359 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Drug Therapy, Combination |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000369 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Aged, 80 and over |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D012074 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Remission Induction |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D006801 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Humans |
| mesh[17].qualifier_ui | Q000188 |
| mesh[17].descriptor_ui | D013700 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | drug therapy |
| mesh[17].descriptor_name | Giant Cell Arteritis |
| mesh[18].qualifier_ui | Q000000981 |
| mesh[18].descriptor_ui | D013700 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | diagnostic imaging |
| mesh[18].descriptor_name | Giant Cell Arteritis |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D061067 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[20].qualifier_ui | Q000008 |
| mesh[20].descriptor_ui | D061067 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | administration & dosage |
| mesh[20].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D005260 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Female |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008297 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Male |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D000368 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Aged |
| mesh[24].qualifier_ui | Q000008 |
| mesh[24].descriptor_ui | D005938 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | administration & dosage |
| mesh[24].descriptor_name | Glucocorticoids |
| mesh[25].qualifier_ui | Q000627 |
| mesh[25].descriptor_ui | D005938 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | therapeutic use |
| mesh[25].descriptor_name | Glucocorticoids |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D016896 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Treatment Outcome |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000072078 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Positron Emission Tomography Computed Tomography |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D008875 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Middle Aged |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D004359 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Drug Therapy, Combination |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000369 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Aged, 80 and over |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D012074 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Remission Induction |
| type | article |
| title | Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study |
| biblio.issue | 5 |
| biblio.volume | 64 |
| biblio.last_page | 3062 |
| biblio.first_page | 3057 |
| topics[0].id | https://openalex.org/T10697 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Vasculitis and related conditions |
| topics[1].id | https://openalex.org/T12438 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9976000189781189 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2745 |
| topics[1].subfield.display_name | Rheumatology |
| topics[1].display_name | Urticaria and Related Conditions |
| topics[2].id | https://openalex.org/T14015 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9947999715805054 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2745 |
| topics[2].subfield.display_name | Rheumatology |
| topics[2].display_name | Otitis Media and Relapsing Polychondritis |
| is_xpac | False |
| apc_list.value | 3192 |
| apc_list.currency | GBP |
| apc_list.value_usd | 3915 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9413577318191528 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2777178219 |
| concepts[1].level | 3 |
| concepts[1].score | 0.922421932220459 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q425154 |
| concepts[1].display_name | Tocilizumab |
| concepts[2].id | https://openalex.org/C2776712624 |
| concepts[2].level | 4 |
| concepts[2].score | 0.8730550408363342 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q707816 |
| concepts[2].display_name | Giant cell arteritis |
| concepts[3].id | https://openalex.org/C2778029271 |
| concepts[3].level | 2 |
| concepts[3].score | 0.48257699608802795 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q5421931 |
| concepts[3].display_name | Extension (predicate logic) |
| concepts[4].id | https://openalex.org/C2776715498 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4346250891685486 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11426176 |
| concepts[4].display_name | Prednisolone |
| concepts[5].id | https://openalex.org/C16005928 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4302852749824524 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q171171 |
| concepts[5].display_name | Dermatology |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3824339807033539 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C2776015282 |
| concepts[7].level | 3 |
| concepts[7].score | 0.30833789706230164 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q644318 |
| concepts[7].display_name | Vasculitis |
| concepts[8].id | https://openalex.org/C2777575956 |
| concepts[8].level | 2 |
| concepts[8].score | 0.12221801280975342 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q187255 |
| concepts[8].display_name | Rheumatoid arthritis |
| concepts[9].id | https://openalex.org/C2779134260 |
| concepts[9].level | 2 |
| concepts[9].score | 0.08893916010856628 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[9].display_name | Disease |
| concepts[10].id | https://openalex.org/C41008148 |
| concepts[10].level | 0 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[10].display_name | Computer science |
| concepts[11].id | https://openalex.org/C199360897 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q9143 |
| concepts[11].display_name | Programming language |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9413577318191528 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/tocilizumab |
| keywords[1].score | 0.922421932220459 |
| keywords[1].display_name | Tocilizumab |
| keywords[2].id | https://openalex.org/keywords/giant-cell-arteritis |
| keywords[2].score | 0.8730550408363342 |
| keywords[2].display_name | Giant cell arteritis |
| keywords[3].id | https://openalex.org/keywords/extension |
| keywords[3].score | 0.48257699608802795 |
| keywords[3].display_name | Extension (predicate logic) |
| keywords[4].id | https://openalex.org/keywords/prednisolone |
| keywords[4].score | 0.4346250891685486 |
| keywords[4].display_name | Prednisolone |
| keywords[5].id | https://openalex.org/keywords/dermatology |
| keywords[5].score | 0.4302852749824524 |
| keywords[5].display_name | Dermatology |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.3824339807033539 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/vasculitis |
| keywords[7].score | 0.30833789706230164 |
| keywords[7].display_name | Vasculitis |
| keywords[8].id | https://openalex.org/keywords/rheumatoid-arthritis |
| keywords[8].score | 0.12221801280975342 |
| keywords[8].display_name | Rheumatoid arthritis |
| keywords[9].id | https://openalex.org/keywords/disease |
| keywords[9].score | 0.08893916010856628 |
| keywords[9].display_name | Disease |
| language | en |
| locations[0].id | doi:10.1093/rheumatology/keae400 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S183989336 |
| locations[0].source.issn | 1462-0324, 1462-0332 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1462-0324 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Lara D. Veeken |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Rheumatology |
| locations[0].landing_page_url | https://doi.org/10.1093/rheumatology/keae400 |
| locations[1].id | pmid:39150490 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Rheumatology (Oxford, England) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39150490 |
| locations[2].id | pmh:oai:iris.unimore.it:11380/1354146 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400718 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | IRIS UNIMORE (University of Modena and Reggio Emilia) |
| locations[2].source.host_organization | https://openalex.org/I122346577 |
| locations[2].source.host_organization_name | University of Modena and Reggio Emilia |
| locations[2].source.host_organization_lineage | https://openalex.org/I122346577 |
| locations[2].license | cc-by |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | info:eu-repo/semantics/article |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://hdl.handle.net/11380/1354146 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5087255420 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0362-2668 |
| authorships[0].author.display_name | Francesco Muratore |
| authorships[0].countries | IT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I122346577 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Modena and Reggio Emilia , Modena, Italy |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210090508 |
| authorships[0].affiliations[1].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[0].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[0].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[0].institutions[0].country_code | IT |
| authorships[0].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[0].institutions[1].id | https://openalex.org/I122346577 |
| authorships[0].institutions[1].ror | https://ror.org/02d4c4y02 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I122346577 |
| authorships[0].institutions[1].country_code | IT |
| authorships[0].institutions[1].display_name | University of Modena and Reggio Emilia |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Francesco Muratore |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy, University of Modena and Reggio Emilia , Modena, Italy |
| authorships[1].author.id | https://openalex.org/A5045766157 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-7027-1410 |
| authorships[1].author.display_name | Chiara Marvisi |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I122346577 |
| authorships[1].affiliations[0].raw_affiliation_string | University of Modena and Reggio Emilia , Modena, Italy |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210090508 |
| authorships[1].affiliations[1].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[1].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[1].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[1].institutions[1].id | https://openalex.org/I122346577 |
| authorships[1].institutions[1].ror | https://ror.org/02d4c4y02 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I122346577 |
| authorships[1].institutions[1].country_code | IT |
| authorships[1].institutions[1].display_name | University of Modena and Reggio Emilia |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Chiara Marvisi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy, University of Modena and Reggio Emilia , Modena, Italy |
| authorships[2].author.id | https://openalex.org/A5067979684 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3454-401X |
| authorships[2].author.display_name | Giulia Cassone |
| authorships[2].countries | IT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210109058 |
| authorships[2].affiliations[0].raw_affiliation_string | Rheumatology Unit, Azienda Ospedaliero-Universitaria di Modena , Modena, Italy |
| authorships[2].institutions[0].id | https://openalex.org/I4210109058 |
| authorships[2].institutions[0].ror | https://ror.org/01hmmsr16 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210109058 |
| authorships[2].institutions[0].country_code | IT |
| authorships[2].institutions[0].display_name | Azienda Ospedaliero-Universitaria di Modena |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Giulia Cassone |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Rheumatology Unit, Azienda Ospedaliero-Universitaria di Modena , Modena, Italy |
| authorships[3].author.id | https://openalex.org/A5080755340 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Caterina Ricordi |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[3].affiliations[0].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I122346577 |
| authorships[3].affiliations[1].raw_affiliation_string | University of Modena and Reggio Emilia , Modena, Italy |
| authorships[3].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[3].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[3].institutions[1].id | https://openalex.org/I122346577 |
| authorships[3].institutions[1].ror | https://ror.org/02d4c4y02 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I122346577 |
| authorships[3].institutions[1].country_code | IT |
| authorships[3].institutions[1].display_name | University of Modena and Reggio Emilia |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Caterina Ricordi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy, University of Modena and Reggio Emilia , Modena, Italy |
| authorships[4].author.id | https://openalex.org/A5026514426 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Luigi Boiardi |
| authorships[4].countries | IT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[4].affiliations[0].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[4].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[4].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[4].institutions[0].country_code | IT |
| authorships[4].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Luigi Boiardi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[5].author.id | https://openalex.org/A5079851057 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1609-2440 |
| authorships[5].author.display_name | Pamela Mancuso |
| authorships[5].countries | IT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[5].affiliations[0].raw_affiliation_string | Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[5].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[5].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[5].institutions[0].country_code | IT |
| authorships[5].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Pamela Mancuso |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[6].author.id | https://openalex.org/A5077265390 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5319-5495 |
| authorships[6].author.display_name | Giulia Besutti |
| authorships[6].countries | IT |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[6].affiliations[0].raw_affiliation_string | Radiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I122346577 |
| authorships[6].affiliations[1].raw_affiliation_string | University of Modena and Reggio Emilia , Modena, Italy |
| authorships[6].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[6].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[6].institutions[0].country_code | IT |
| authorships[6].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[6].institutions[1].id | https://openalex.org/I122346577 |
| authorships[6].institutions[1].ror | https://ror.org/02d4c4y02 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I122346577 |
| authorships[6].institutions[1].country_code | IT |
| authorships[6].institutions[1].display_name | University of Modena and Reggio Emilia |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Giulia Besutti |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Radiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy, University of Modena and Reggio Emilia , Modena, Italy |
| authorships[7].author.id | https://openalex.org/A5103912878 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Lucia Spaggiari |
| authorships[7].countries | IT |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[7].affiliations[0].raw_affiliation_string | Radiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[7].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[7].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[7].institutions[0].country_code | IT |
| authorships[7].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Lucia Spaggiari |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Radiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[8].author.id | https://openalex.org/A5070205249 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3832-8696 |
| authorships[8].author.display_name | Massimiliano Casali |
| authorships[8].countries | IT |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210103438 |
| authorships[8].affiliations[0].raw_affiliation_string | Nuclear Medicine Unit, Azienda Unità Sanitaria Locale di Piacenza , Piacenza, Italy |
| authorships[8].institutions[0].id | https://openalex.org/I4210103438 |
| authorships[8].institutions[0].ror | https://ror.org/01j1w4v71 |
| authorships[8].institutions[0].type | government |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210103438 |
| authorships[8].institutions[0].country_code | IT |
| authorships[8].institutions[0].display_name | Azienda Unità Sanitaria Locale Piacenza |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Massimiliano Casali |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Nuclear Medicine Unit, Azienda Unità Sanitaria Locale di Piacenza , Piacenza, Italy |
| authorships[9].author.id | https://openalex.org/A5066850001 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-8622-0439 |
| authorships[9].author.display_name | Stefania Croci |
| authorships[9].countries | IT |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210090508, https://openalex.org/I4210153126 |
| authorships[9].affiliations[0].raw_affiliation_string | Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[9].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[9].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[9].institutions[0].country_code | IT |
| authorships[9].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[9].institutions[1].id | https://openalex.org/I4210153126 |
| authorships[9].institutions[1].ror | https://ror.org/04tfzc498 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210153126 |
| authorships[9].institutions[1].country_code | IT |
| authorships[9].institutions[1].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Stefania Croci |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[10].author.id | https://openalex.org/A5070972643 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Rexhep Durmo |
| authorships[10].countries | IT |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[10].affiliations[0].raw_affiliation_string | Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[10].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[10].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[10].institutions[0].country_code | IT |
| authorships[10].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Rexhep Durmo |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[11].author.id | https://openalex.org/A5045569134 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-8675-2435 |
| authorships[11].author.display_name | Annibale Versari |
| authorships[11].countries | IT |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[11].affiliations[0].raw_affiliation_string | Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[11].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[11].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[11].institutions[0].country_code | IT |
| authorships[11].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Annibale Versari |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[12].author.id | https://openalex.org/A5114209590 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Gabriella Di Tommaso |
| authorships[12].countries | IT |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[12].affiliations[0].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[12].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[12].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[12].institutions[0].country_code | IT |
| authorships[12].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Gabriella Di Tommaso |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[13].author.id | https://openalex.org/A5070952311 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-4155-6094 |
| authorships[13].author.display_name | Mariagrazia Catanoso |
| authorships[13].countries | IT |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[13].affiliations[0].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[13].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[13].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[13].institutions[0].country_code | IT |
| authorships[13].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Mariagrazia Catanoso |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[14].author.id | https://openalex.org/A5045367285 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9703-2460 |
| authorships[14].author.display_name | Paolo Giorgi Rossi |
| authorships[14].countries | IT |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210090508 |
| authorships[14].affiliations[0].raw_affiliation_string | Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[14].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[14].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[14].institutions[0].country_code | IT |
| authorships[14].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Paolo Giorgi Rossi |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[15].author.id | https://openalex.org/A5102847303 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-3708-3148 |
| authorships[15].author.display_name | Carlo Salvarani |
| authorships[15].countries | IT |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I122346577 |
| authorships[15].affiliations[0].raw_affiliation_string | University of Modena and Reggio Emilia , Modena, Italy |
| authorships[15].affiliations[1].institution_ids | https://openalex.org/I4210090508 |
| authorships[15].affiliations[1].raw_affiliation_string | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy |
| authorships[15].institutions[0].id | https://openalex.org/I4210090508 |
| authorships[15].institutions[0].ror | https://ror.org/001bbwj30 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210090508 |
| authorships[15].institutions[0].country_code | IT |
| authorships[15].institutions[0].display_name | Azienda Sanitaria Unità Locale di Reggio Emilia |
| authorships[15].institutions[1].id | https://openalex.org/I122346577 |
| authorships[15].institutions[1].ror | https://ror.org/02d4c4y02 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I122346577 |
| authorships[15].institutions[1].country_code | IT |
| authorships[15].institutions[1].display_name | University of Modena and Reggio Emilia |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Carlo Salvarani |
| authorships[15].is_corresponding | True |
| authorships[15].raw_affiliation_strings | Rheumatology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia , Reggio Emilia, Italy, University of Modena and Reggio Emilia , Modena, Italy |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://hdl.handle.net/11380/1354146 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10697 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Vasculitis and related conditions |
| related_works | https://openalex.org/W2093526042, https://openalex.org/W1968260519, https://openalex.org/W2307127799, https://openalex.org/W2792261031, https://openalex.org/W2737436316, https://openalex.org/W2550140927, https://openalex.org/W2784384431, https://openalex.org/W2089514348, https://openalex.org/W2100028348, https://openalex.org/W4205149088 |
| cited_by_count | 5 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:iris.unimore.it:11380/1354146 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400718 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | IRIS UNIMORE (University of Modena and Reggio Emilia) |
| best_oa_location.source.host_organization | https://openalex.org/I122346577 |
| best_oa_location.source.host_organization_name | University of Modena and Reggio Emilia |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I122346577 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | info:eu-repo/semantics/article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://hdl.handle.net/11380/1354146 |
| primary_location.id | doi:10.1093/rheumatology/keae400 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S183989336 |
| primary_location.source.issn | 1462-0324, 1462-0332 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1462-0324 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Lara D. Veeken |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Rheumatology |
| primary_location.landing_page_url | https://doi.org/10.1093/rheumatology/keae400 |
| publication_date | 2024-08-16 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4296590630, https://openalex.org/W2737436316, https://openalex.org/W2292169217, https://openalex.org/W4389966111, https://openalex.org/W4376871832, https://openalex.org/W3177475870, https://openalex.org/W4388248906, https://openalex.org/W2954943567, https://openalex.org/W2769898966, https://openalex.org/W3135997688, https://openalex.org/W4393055244, https://openalex.org/W4385988065, https://openalex.org/W4376595521 |
| referenced_works_count | 13 |
| abstract_inverted_index.3 | 32 |
| abstract_inverted_index.6 | 153 |
| abstract_inverted_index.a | 62, 127 |
| abstract_inverted_index.17 | 23 |
| abstract_inverted_index.52 | 44, 53 |
| abstract_inverted_index.78 | 96, 115, 176 |
| abstract_inverted_index.CI | 195, 201 |
| abstract_inverted_index.HR | 207 |
| abstract_inverted_index.To | 2 |
| abstract_inverted_index.at | 51, 73, 94, 113, 117, 134, 174, 178 |
| abstract_inverted_index.in | 18, 41, 47, 70, 88, 130, 230, 235, 238 |
| abstract_inverted_index.of | 6, 8, 11, 34, 76, 107, 120, 168, 181, 214, 225 |
| abstract_inverted_index.to | 143 |
| abstract_inverted_index.148 | 189 |
| abstract_inverted_index.4.6 | 164 |
| abstract_inverted_index.52, | 103, 149 |
| abstract_inverted_index.78, | 136 |
| abstract_inverted_index.95% | 194, 200 |
| abstract_inverted_index.Age | 204 |
| abstract_inverted_index.CI) | 139, 162, 209 |
| abstract_inverted_index.End | 83 |
| abstract_inverted_index.One | 223 |
| abstract_inverted_index.PET | 89 |
| abstract_inverted_index.TCZ | 40, 55, 156, 187, 226, 242 |
| abstract_inverted_index.The | 166 |
| abstract_inverted_index.all | 71 |
| abstract_inverted_index.and | 37, 56, 100, 104, 116, 177, 197, 205 |
| abstract_inverted_index.end | 75, 119, 180 |
| abstract_inverted_index.for | 43, 210 |
| abstract_inverted_index.its | 16 |
| abstract_inverted_index.may | 244 |
| abstract_inverted_index.one | 9 |
| abstract_inverted_index.the | 4, 74, 77, 86, 105, 118, 121, 179, 182 |
| abstract_inverted_index.was | 61, 68, 132, 191, 219, 228 |
| abstract_inverted_index.(95% | 138, 161, 208 |
| abstract_inverted_index.1.36 | 220 |
| abstract_inverted_index.78), | 159 |
| abstract_inverted_index.78). | 82 |
| abstract_inverted_index.8/17 | 198 |
| abstract_inverted_index.each | 211 |
| abstract_inverted_index.from | 186 |
| abstract_inverted_index.mean | 137, 160 |
| abstract_inverted_index.part | 58 |
| abstract_inverted_index.time | 185 |
| abstract_inverted_index.two, | 59 |
| abstract_inverted_index.unit | 212 |
| abstract_inverted_index.week | 52, 95, 102, 114, 135, 148 |
| abstract_inverted_index.were | 28, 85 |
| abstract_inverted_index.with | 25, 31, 98, 101, 109, 125, 147, 170 |
| abstract_inverted_index.year | 10, 224 |
| abstract_inverted_index.(47%, | 199 |
| abstract_inverted_index.(65%, | 193 |
| abstract_inverted_index.(TCZ) | 13 |
| abstract_inverted_index.(week | 81, 158 |
| abstract_inverted_index.11/17 | 192 |
| abstract_inverted_index.Trial | 248 |
| abstract_inverted_index.after | 15, 155, 241 |
| abstract_inverted_index.early | 240 |
| abstract_inverted_index.large | 19 |
| abstract_inverted_index.score | 92 |
| abstract_inverted_index.weeks | 175 |
| abstract_inverted_index.which | 60 |
| abstract_inverted_index.LV-GCA | 27 |
| abstract_inverted_index.PET/CT | 67 |
| abstract_inverted_index.PETVAS | 131, 150, 215, 239 |
| abstract_inverted_index.active | 26 |
| abstract_inverted_index.assess | 3 |
| abstract_inverted_index.change | 140, 163 |
| abstract_inverted_index.months | 154 |
| abstract_inverted_index.period | 80 |
| abstract_inverted_index.points | 84 |
| abstract_inverted_index.weekly | 38 |
| abstract_inverted_index.weeks) | 190 |
| abstract_inverted_index.weeks. | 45 |
| abstract_inverted_index.−6.6 | 141 |
| abstract_inverted_index.(median | 184 |
| abstract_inverted_index.(−9.5 | 142 |
| abstract_inverted_index.26-week | 63, 78 |
| abstract_inverted_index.Changes | 237 |
| abstract_inverted_index.LV-GCA. | 236 |
| abstract_inverted_index.Methods | 22 |
| abstract_inverted_index.Results | 123 |
| abstract_inverted_index.boluses | 33 |
| abstract_inverted_index.entered | 57 |
| abstract_inverted_index.period. | 66 |
| abstract_inverted_index.predict | 245 |
| abstract_inverted_index.relapse | 218 |
| abstract_inverted_index.treated | 30 |
| abstract_inverted_index.(PETVAS) | 93 |
| abstract_inverted_index.38–86) | 196 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Compared | 124 |
| abstract_inverted_index.However, | 145 |
| abstract_inverted_index.Patients | 46 |
| abstract_inverted_index.activity | 91 |
| abstract_inverted_index.baseline | 99 |
| abstract_inverted_index.clinical | 49, 111, 172, 233 |
| abstract_inverted_index.compared | 97, 146 |
| abstract_inverted_index.efficacy | 7 |
| abstract_inverted_index.increase | 152, 213 |
| abstract_inverted_index.observed | 133 |
| abstract_inverted_index.patients | 24, 72, 108, 169 |
| abstract_inverted_index.vascular | 90 |
| abstract_inverted_index.−3.7). | 144 |
| abstract_inverted_index.(LV-GCA). | 21 |
| abstract_inverted_index.23–72), | 202 |
| abstract_inverted_index.baseline, | 126 |
| abstract_inverted_index.drug-free | 232 |
| abstract_inverted_index.effective | 229 |
| abstract_inverted_index.follow-up | 65, 183 |
| abstract_inverted_index.performed | 69 |
| abstract_inverted_index.reduction | 129 |
| abstract_inverted_index.relapses. | 247 |
| abstract_inverted_index.remission | 50, 112, 173, 234 |
| abstract_inverted_index.variation | 87 |
| abstract_inverted_index.Objectives | 1 |
| abstract_inverted_index.follow-up. | 122 |
| abstract_inverted_index.indicating | 216 |
| abstract_inverted_index.previously | 29 |
| abstract_inverted_index.proportion | 106, 167 |
| abstract_inverted_index.subsequent | 217, 246 |
| abstract_inverted_index.vessel-GCA | 20 |
| abstract_inverted_index.Conclusions | 222 |
| abstract_inverted_index.intravenous | 35 |
| abstract_inverted_index.maintaining | 231 |
| abstract_inverted_index.maintenance | 5 |
| abstract_inverted_index.monotherapy | 14, 42, 227 |
| abstract_inverted_index.significant | 128 |
| abstract_inverted_index.tocilizumab | 12 |
| abstract_inverted_index.(0.7–8.5). | 165 |
| abstract_inverted_index.NCT05394909. | 252 |
| abstract_inverted_index.discontinued | 54 |
| abstract_inverted_index.registration | 249 |
| abstract_inverted_index.relapse-free | 48, 110, 171 |
| abstract_inverted_index.sex-adjusted | 206 |
| abstract_inverted_index.subcutaneous | 39 |
| abstract_inverted_index.observational | 64, 79 |
| abstract_inverted_index.respectively. | 203 |
| abstract_inverted_index.significantly | 151 |
| abstract_inverted_index.(0.92–2.00). | 221 |
| abstract_inverted_index.discontinuation | 17, 157, 188, 243 |
| abstract_inverted_index.methylprednisone | 36 |
| abstract_inverted_index.ClinicalTrials.gov, | 250 |
| abstract_inverted_index.http://clinicaltrials.gov, | 251 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5102847303 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 16 |
| corresponding_institution_ids | https://openalex.org/I122346577, https://openalex.org/I4210090508 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.91494434 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |